Elisabeth I. Minder
- Molecular Biology top 10%
- Cardiology and Cardiovascular Medicine top 5%
- Rheumatology top 5%
- Pulmonary and Respiratory Medicine top 10%
- Epidemiology top 10%
- Co-authors
- Xiaoye Schneider‐YinOsmund BertelThomas FehrPeter AmmannC. I. GünterJasmin Barman‐AksözenJean‐Charles DeybachChristoph E. Minder
- Topics
- Porphyrin Metabolism and Disorders (55 papers)Heme Oxygenase-1 and Carbon Monoxide (27 papers)Folate and B Vitamins Research (25 papers)
- Partner nations
- SwitzerlandFranceNetherlands
In The Last Decade
Elisabeth I. Minder
80 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 111
- Molecular Biology 965
- Cardiology and Cardiovascular Medicine 520
- Rheumatology 303
- Pulmonary and Respiratory Medicine 290
- Epidemiology 276
Countries citing papers authored by Elisabeth I. Minder
This map shows the geographic impact of Elisabeth I. Minder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth I. Minder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth I. Minder more than expected).
Fields of papers citing papers by Elisabeth I. Minder
This network shows the impact of papers produced by Elisabeth I. Minder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth I. Minder. The network helps show where Elisabeth I. Minder may publish in the future.
Co-authorship network of co-authors of Elisabeth I. Minder
This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth I. Minder. A scholar is included among the top collaborators of Elisabeth I. Minder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth I. Minder. Elisabeth I. Minder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 7 | |
| 3 | 0 | |
| 4 | 22 | |
| 5 | 65 | |
| 6 | 9 | |
| 7 | 19 | |
| 8 | 33 | |
| 9 | 18 | |
| 10 | 4 | |
| 11 | 39 | |
| 12 | 14 | |
| 13 | 80 | |
| 14 | 15 | |
| 15 | 14 | |
| 16 | 278 | |
| 17 | 10 | |
| 18 | 15 | |
| 19 | 45 | |
| 20 | 10 |
About Elisabeth I. Minder
Elisabeth I. Minder is a scholar working on Clinical Biochemistry, Rheumatology and Molecular Biology, having authored 83 papers that have together received 2.0k indexed citations. Recurring topics across this work include Porphyrin Metabolism and Disorders (55 papers), Heme Oxygenase-1 and Carbon Monoxide (27 papers) and Folate and B Vitamins Research (25 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (520 citations), Rheumatology (303 citations) and Virology (91 citations). Elisabeth I. Minder has collaborated with scholars based in Switzerland, France and Netherlands. Frequent co-authors include Xiaoye Schneider‐Yin, Osmund Bertel, Thomas Fehr, Peter Ammann, C. I. Günter, Jasmin Barman‐Aksözen, Jean‐Charles Deybach, Christoph E. Minder, Marco Maggiorini and Helen I. Joller‐Jemelka. Their work appears in journals such as Nucleic Acids Research, Blood and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.